Editorial: New insights in diagnosis and therapy of hormone-dependent cancer

Editorial: New insights in diagnosis and therapy of hormone-dependent cancer

Bibliographic Details
Main Authors:	Monica Rienzo, Cristina Pagano, Felice Crocetto, Erika Di Zazzo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Series:	Frontiers in Endocrinology
Subjects:	hormone-dependent cancers prostate cancer breast cancer endometrial cancer prognosis CtDNA
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2022.1115341/full

Similar Items

BRCA-deficient metastatic prostate cancer has an adverse prognosis and distinct genomic phenotypeResearch in context
by: Heidi Fettke, et al.
Published: (2023-09-01)

Proteoglycans in the Pathogenesis of Hormone-Dependent Cancers: Mediators and Effectors
by: George Tzanakakis, et al.
Published: (2020-08-01)

Circulating Tumor DNA—A Novel Biomarker of Tumor Progression and Its Favorable Detection Techniques
by: Xiaosha Wen, et al.
Published: (2022-12-01)

Liquid Biopsies, Novel Approaches and Future Directions
by: Athanasios Armakolas, et al.
Published: (2023-03-01)

Pancreatic Tumorigenesis: Precursors, Genetic Risk Factors and Screening
by: Mohamed Badheeb, et al.
Published: (2022-11-01)

Role of ctDNA in Breast Cancer
by: Marta Sant, et al.
Published: (2022-01-01)

Case Report: Potential role of selective venous sampling for liquid biopsy in complex clinical settings: Three case presentations
by: Vladimira Tichà, et al.
Published: (2023-03-01)

The androgen-thyroid hormone crosstalk in prostate cancer and the clinical implications
by: Sepehr Torabinejad, et al.
Published: (2023-05-01)

Estimation of ALU Repetitive Elements in Plasma as a Cost-Effective Liquid Biopsy Tool for Disease Prognosis in Breast Cancer
by: Madhumathy G. Nair, et al.
Published: (2023-02-01)

Liquid Biopsy in Diagnosis and Prognosis of Non-Metastatic Prostate Cancer
by: Alexey S. Rzhevskiy, et al.
Published: (2022-12-01)

Novel imaging and circulating biomarkers in hepatic malignancies
by: Winter, H
Published: (2019)

Clinical applications and utility of ctDNA in cervical cancer and its precursor lesions: from screening to predictive biomarker
by: Li Li, et al.
Published: (2023-12-01)

Circulating Tumor Cells: From the Laboratory to the Cancer Clinic
by: Ruchi Agashe, et al.
Published: (2020-08-01)

The Role of ctDNA in Gastric Cancer
by: Justin Mencel, et al.
Published: (2022-10-01)

Genomic alterations of cerebrospinal fluid cell-free DNA in leptomeningeal metastases of gastric cancer
by: Xin Chen, et al.
Published: (2023-05-01)

Sensitive and Specific Analyses of Colorectal Cancer Recurrence through Multiplex superRCA Mutation Detection in Blood Plasma
by: Emma Sandberg, et al.
Published: (2024-01-01)

Targeting DNA Damage Response in Prostate and Breast Cancer
by: Antje M. Wengner, et al.
Published: (2020-11-01)

Circulating tumor DNA as prognostic markers of relapsed breast cancer: a systematic review and meta-analysis
by: Na'na Guo, et al.
Published: (2024-03-01)

The Role of CD4/6 Inhibitors in Breast Cancer Treatment
by: Luv Purohit, et al.
Published: (2024-01-01)

Analysis of circulating tumor DNA: a new concept in clinical oncology
by: Mourad NACHI, et al.
Published: (2021-12-01)

Basic ctDNA Panel Promises Affordable Clinical Validity in Colon Cancer Patients but Not in Pancreas Cancer Patients
by: Mandy Radefeldt, et al.
Published: (2023-11-01)

Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II‐III gastric cancer
by: Shu‐Qiang Yuan, et al.
Published: (2023-12-01)

Clinical Utility of Plasma KRAS, NRAS and BRAF Mutational Analysis with Real Time PCR in Metastatic Colorectal Cancer Patients—The Importance of Tissue/Plasma Discordant Cases
by: Vincenzo Formica, et al.
Published: (2020-12-01)

Editorial: Circulating tumor DNA in cancer: a role as a response and monitoring “next-generation” biomarker in cancer therapy
by: Saeid Latifi-Navid, et al.
Published: (2023-06-01)

Concordance between TP53 alterations in blood and tissue: impact of time interval, biopsy site, cancer type and circulating tumor DNA burden
by: Cheyennedra C. Bieg‐Bourne, et al.
Published: (2020-06-01)

The Potential of Liquid Biopsy in Detection of Endometrial Cancer Biomarkers: A Pilot Study
by: Dominik Kodada, et al.
Published: (2023-04-01)

Circulating Tumor DNA (ctDNA) Clearance May Predict Treatment Response in Neoadjuvant Colorectal Cancer Management
by: Britney Niemann, et al.
Published: (2024-03-01)

Potential Impact of Preoperative Circulating Biomarkers on Individual Escalating/de-Escalating Strategies in Early Breast Cancer
by: Caterina Gianni, et al.
Published: (2022-12-01)

Phytosterols activating nuclear receptors are involving in steroid hormone-dependent cancers: Myth or fact?
by: Saad Bakrim, et al.
Published: (2023-12-01)

Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancer
by: Zhaoyun Liu, et al.
Published: (2023-12-01)

Monitoring treatment efficacy and resistance in breast cancer patients via circulating tumor DNA genomic profiling
by: Zhanhong Chen, et al.
Published: (2020-02-01)

Genetic Contribution of Endometriosis to the Risk of Developing Hormone-Related Cancers
by: Aintzane Rueda-Martínez, et al.
Published: (2021-06-01)

Hormones and cancer /
by: Vedeckis, Wayne V.
Published: (1996)

The Prognostic Importance of ctDNA in Rectal Cancer: A Critical Reappraisal
by: Edina Dizdarevic, et al.
Published: (2022-04-01)

EGFR‐plasma mutations in prognosis for non‐small cell lung cancer treated with EGFR TKIs: A meta‐analysis
by: Thang Thanh Phan, et al.
Published: (2022-08-01)

Targeting the formation of estrogens for treatment of hormone dependent diseases–current status
by: Tea Lanišnik Rižner, et al.
Published: (2023-04-01)

Early detection and prognosis prediction for colorectal cancer by circulating tumour DNA methylation haplotypes: A multicentre cohort studyResearch in context
by: Shaobo Mo, et al.
Published: (2023-01-01)

Role of myeloid-derived suppressor cells in hormone-dependent cancers
by: Siddhartha Mukherjee, et al.
Published: (2021-03-01)

Adiponectin: A player in the pathogenesis of hormone-dependent cancers
by: Alexandra Tsankof, et al.
Published: (2022-10-01)

Clinical Validity of Circulating Tumor DNA as Prognostic and Predictive Marker for Personalized Colorectal Cancer Patient Management
by: Ariane Hallermayr, et al.
Published: (2022-02-01)